HuniLife Biotechnology Competitors and Similar CompaniesClear all
HuniLife Biotechnology's competitors and similar companies include MEI Pharma, Corvus Pharmaceuticals, Replimune and Amolyt Pharma.
 HuniLife Biotechnology HuniLife Biotechnology is a company focused on the treatment of immune and inflammatory diseases as well as cancer. |  MEI Pharma MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. |  Corvus Pharmaceuticals Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. |  Amolyt Pharma Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer. | ||
Founding Date | Founding Date 2013 | Founding Date 2000 | Founding Date 2014 | Founding Date 2015 | Founding Date 2015 |
Type | Type Private | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations TW HQ | Locations San Diego, US HQ | Locations Burlingame, US HQ | Locations Woburn, US HQ Milton, GB Woburn, US | Locations Écully, FR HQ Cambridge, US |
Employees | Employees N/A | Employees 4025% increase | Employees 4911% decrease | Employees 10422% increase | Employees 373% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 21.1 m | Valuation ($) 556.1 m | Valuation ($) 823.3 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income $17.8m (FY, 2024) | Net income ($15.3m) (FY, 2025) | Net income ($247.3m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.1m | Total funding raised N/A | Total funding raised $ 30m | Total funding raised $ 93.1m |
For sources of this data, please see the company profile
View Company Profiles
MEI Pharma
HQ
San Diego, US
Employees
40↑ 25% increase
MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.
View companyCorvus Pharmaceuticals
HQ
Burlingame, US
Employees
49↓ 11% decrease
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.
View company
Replimune
HQ
Woburn, US
Employees
104↑ 22% increase
Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.
View companyAmolyt Pharma
HQ
Écully, FR
Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
View company